Loading...
Back
NSPR
NN
INSPIRA TECHNOLOGIES OXY BHN LTD
(IINN)
2025 6-K
Follow
Summary
Share
Summary
Equity Facilities Termination
31 Mar '26
Company Update
26 Mar '26
New Subsidiary Established
26 Mar '26
Debenture Amendment
25 Feb '26
Expansion Announcement
18 Feb '26
Sales Agreement Executed
17 Feb '26
Nasdaq Notification
12 Feb '26
Vendor Approval Secured
9 Feb '26
Funding Agreement
6 Feb '26
New Blood Sensor
3 Feb '26
Clinical Evaluation Success
29 Jan '26
Government Validation Progress
21 Jan '26
Acquisition Announcement
13 Jan '26
Strategic Vision Update
8 Jan '26
Acquisition Announcement
5 Jan '26
General Meeting Held
31 Dec '25
Purchase Order Confirmation
23 Dec '25
Equity Financing Announcement
15 Dec '25
Patent Granted
9 Dec '25
Lab Capabilities Update
3 Dec '25
Meeting Notice Filed
25 Nov '25
Clinical Study Completion
13 Nov '25
Regulatory Update
6 Nov '25
Strategic Alliance
22 Oct '25
Management Change
21 Oct '25
Financial Update
1 Oct '25
New Sensor Announcement
18 Sep '25
Share Offering Update
16 Sep '25
FDA Submission Update
11 Sep '25
Hospital Adoption Update
2 Sep '25
Patent Approval Received
22 Aug '25
Government Order Secured
19 Aug '25
Consulting Firm Activation
31 Jul '25
Compliance Regained
18 Jul '25
Director Resignation
17 Jul '25
Government Talks Success
10 Jul '25
Government Talks Update
7 Jul '25
Major Purchase Order
2 Jul '25
Share Offering Increase
1 Jul '25
Shareholder Meeting
23 Jun '25
Clinical Interest Growth
11 Jun '25
Production Expansion
5 Jun '25
Shareholder Meeting Notice
30 May '25
Global Rollout Initiated
29 May '25
Executive Team Update
27 May '25
Shareholder Approval
12 May '25
FDA Approval Announcement
7 May '25
Gas Exchange Efficiency
23 Apr '25
First Revenue Generated
15 Apr '25
Capital Increase Filed
10 Apr '25
Shareholders Meeting
7 Apr '25
Patient Treatment Success
7 Apr '25
Successful Installation
25 Mar '25
Sales Agreement Signed
14 Mar '25
CEO Update Released
14 Mar '25
Nasdaq Notification
13 Mar '25
Financial Results Report
11 Mar '25
Clinical Study Results
4 Mar '25
Positive Results
11 Feb '25
Strategic Position Update
10 Feb '25
New Product Integration
5 Feb '25
Product Launch Update
27 Jan '25
Board Changes
21 Jan '25
Partnership Announcement
17 Jan '25
New Technology Unveiled
14 Jan '25
Production Response
10 Jan '25
Event Showcase Announcement
7 Jan '25
Annual Meeting Results
30 Dec '24
Private Placement Announcement
27 Dec '24
Systems Delivery Announcement
16 Dec '24
Technology Expansion
10 Dec '24
New Collaboration
4 Dec '24
Shareholder Meeting Notice
25 Nov '24
Investor Presentation
12 Nov '24
New Facility Announcement
24 Oct '24
New Product Announcement
9 Oct '24
Patent Approval Secured
13 Sep '24
Clinical Results Announcement
28 Aug '24
FDA Approval Announcement
22 Aug '24
Interim Financial Report
15 Aug '24
Product Evaluation Update
13 Aug '24
Product Launch Announcement
30 Jul '24
Regulatory Approval
11 Jul '24
Business Plan Announcement
20 Jun '24
Amended Filing
18 Jun '24
Share Issuance Agreement
17 Jun '24
Purchase Order Granted
13 Jun '24
FDA Clearance Achieved
28 May '24
Product Launch
2 May '24
Certification Received
25 Apr '24
Press Release Summary
17 Apr '24
Bacterial Growth Prevention
10 Apr '24
Shareholder Meeting Approval
9 Apr '24
Artificial Womb Program
3 Apr '24
Share Offering Announcement
1 Apr '24
Financial Results Report
25 Mar '24
Regulatory Submission
18 Mar '24
New Technology Data
12 Mar '24
Extraordinary Meeting Notice
8 Mar '24
Extraordinary Meeting Notice
4 Mar '24
Research Announcement
4 Mar '24
FDA Approval Update
27 Feb '24
New Platform Introduction
22 Feb '24
Patent Approval
14 Feb '24
New Collaboration
8 Feb '24
Strategic Agreement
30 Jan '24
New Product Announcement
9 Jan '24
New Partnership Agreement
2 Jan '24
External Links:
SEC
On January 17, 2025, Inspira Technologies OXY B.H.N. Ltd announced a collaboration with Zriha Medical to launch a new production line.
AI Assistant
Close
INSPIRA TECHNOLOGIES OXY BHN LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.